Die Katheterablation ist eine sichere und effiziente Behandlungsform bei Vorhofflimmern. Wie die aktuelle Studienlage zeigt, gilt dies für ältere Patienten ebenso wie für jüngere.
Literatur
Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med Oct 1 2002;113:359–364.
Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European heart journal Oct 7 2016;37:2893–2962.
Kirchhof P, Goette A, Gulba D, Hindricks G, Hohnloser SH. Kommentar zu den Leitlinien der ESC zum Vorhofflimmern. Kardiologe 2012;6:12–27.
Hijazi Z, Lindback J, Alexander JH, et al. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. European heart journal May 21 2016;37:1582–1590.
Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet Mar 15 2014;383:955–962.
January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation Jul 9 2019;140:e125–e151.
Andreotti F, Rocca B, Husted S, et al. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. European heart journal Dec 7 2015;36:3238–3249.
Zado E, Callans DJ, Riley M, et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. Journal of cardiovascular electrophysiology Jun 2008;19:621–626.
Corrado A, Patel D, Riedlbauchova L, et al. Efficacy, safety, and outcome of atrial fibrillation ablation in septuagenarians. Journal of cardiovascular electrophysiology Aug 2008;19:807–811.
Bunch TJ, May HT, Bair TL, et al. The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter Ablation. Journal of cardiovascular electrophysiology Feb 2016;27:141–146.
Santangeli P, Di Biase L, Mohanty P, et al. Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes. Journal of cardiovascular electrophysiology Jul 2012;23:687–693.
Spragg DD, Dalal D, Cheema A, et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. Journal of cardiovascular electrophysiology Jun 2008;19:627–631.
Moser JM, Willems S, Andresen D, et al. Complication Rates of Catheter Ablation of Atrial Fibrillation in Patients Aged >/=75 Years versus <75 Years-Results from the German Ablation Registry. Journal of cardiovascular electrophysiology Mar 2017;28:258–265.
Nademanee K, Amnueypol M, Lee F, et al. Benefits and risks of catheter ablation in elderly patients with atrial fibrillation. Heart rhythm Jan 2015;12:44–51.
Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Journal of interventional cardiac electrophysiology Oct 2017;50:1–55.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stöckigt, F., Horlitz, M. Ablation von Vorhofflimmern: Wann, wie und bei wem?. Geriatr Rep 14, 19–21 (2019). https://doi.org/10.1007/s42090-019-0266-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42090-019-0266-8